Corporate-backed communication and collaboration platform Slack is targeting the summer for a direct listing on NYSE that will enable Comcast, SoftBank and Alphabet to exit.

The corporate-backed genome editing technology developer Precision BioSciences, which was spun out of Duke University, floated in the middle of its range and is now valued at more than $780m.

The Baxter and Amgen-backed genome editing technology developer floated in the middle of its range and is now valued at more than $780m.

The ADT, BMW and Duchossois Group-backed family tracking platform is reportedly looking at Australia for an initial public offering that could value it at $675m.

Online mattress retailer Casper Sleep is looking to hire underwriters for an initial public offering that would allow Target to exit two years after leading its $170m series C round.

Hookipa Pharma, a Boehringer Ingelheim, Takeda and Gilead-backed infectious disease and cancer drug developer, has filed for an $86.3m IPO.

Profitable video conferencing technology provider Zoom has filed to go public, with Qualcomm Ventures set to record an exit.

Eli Lilly and GlaxoSmithKline-backed cancer treatment developer Turning Point Therapeutics has filed to raise up to $100m having secured $145m in VC funding.

The Rakuten-backed social media company, which was valued at more than $12bn in 2017, has filed to list on the New York Stock Exchange.

The Alibaba, Foxconn, Legend Holdings and SK Group-backed image recognition software provider is reportedly weighing up New York and Hong Kong for an $800m initial public offering.